| __timestamp | Takeda Pharmaceutical Company Limited | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 612613000000 | 2999000 |
| Thursday, January 1, 2015 | 650773000000 | 10393000 |
| Friday, January 1, 2016 | 619061000000 | 15994000 |
| Sunday, January 1, 2017 | 628106000000 | 26975000 |
| Monday, January 1, 2018 | 717599000000 | 39509000 |
| Tuesday, January 1, 2019 | 964737000000 | 48869000 |
| Wednesday, January 1, 2020 | 875663000000 | 42510000 |
| Friday, January 1, 2021 | 886361000000 | 46105000 |
| Saturday, January 1, 2022 | 997309000000 | 50513000 |
| Sunday, January 1, 2023 | 1053819000000 | 51292000 |
| Monday, January 1, 2024 | 1053819000000 |
Unleashing the power of data
In the world of pharmaceuticals, strategic spending on Selling, General, and Administrative (SG&A) expenses can be a key differentiator. Takeda Pharmaceutical Company Limited, a global leader, has consistently demonstrated robust SG&A spending, with a notable increase of approximately 72% from 2014 to 2023. In contrast, Wave Life Sciences Ltd., a smaller player, has shown a more modest growth in SG&A expenses, increasing by around 1,600% over the same period, albeit from a much smaller base.
From 2014 to 2023, Takeda's SG&A expenses surged, reflecting its expansive global operations and strategic investments. Meanwhile, Wave Life Sciences, despite its smaller scale, has shown significant growth, indicating its aggressive push into the market. The data for 2024 is incomplete, highlighting the dynamic nature of financial reporting and the need for continuous monitoring.
Who Optimizes SG&A Costs Better? Sanofi or Takeda Pharmaceutical Company Limited
Cost Management Insights: SG&A Expenses for Gilead Sciences, Inc. and Takeda Pharmaceutical Company Limited
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Sarepta Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Corcept Therapeutics Incorporated
Selling, General, and Administrative Costs: Takeda Pharmaceutical Company Limited vs Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Takeda Pharmaceutical Company Limited and Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated Trends and Insights
Comparing SG&A Expenses: Apellis Pharmaceuticals, Inc. vs Wave Life Sciences Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? MorphoSys AG or Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Catalyst Pharmaceuticals, Inc. or Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Geron Corporation or Wave Life Sciences Ltd.
Wave Life Sciences Ltd. and Novavax, Inc.: SG&A Spending Patterns Compared